MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect

Journal of Pineal Research

Volumn 51, Issue 3, 2011, Pages 345-352

  Lee, Seung Eun ^a   Kim, Seung Jun ^b,c   Youn, Jong Pil ^c   Hwang, Seung Yong ^b,c   Park, Cheung Seog ^a   Park, Yong Seek ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Hanyang University   (South Korea)

^c GenoCheck Co Ltd   (South Korea)

Author keywords

anticancer effect; breast cancer; gene expression profiling; melatonin; microRNA

Indexed keywords

MELATONIN; MICRORNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; MELATONIN; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80053188423     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00896.x     Document Type: Article

References (50)

1. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Zeng Y,. Principles of micro-RNA production and maturation. Oncogene 2006; 25: 6156-6162. (Pubitemid 44527845)
3. Krek A, Grun D, Poy MN, et al., Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500. (Pubitemid 40617277)
4. Hayashita Y, Osada H, Tatematsu Y, et al., A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-9632. (Pubitemid 41541436)
5. Jovanovic M, Hengartner MO,. miRNAs and apoptosis: RNAs to die for. Oncogene 2006; 25: 6176-6187. (Pubitemid 44527848)
6. Schickel R, Boyerinas B, Park SM, et al., MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959-5974.
7. Volinia S, Calin GA, Liu CG, et al., A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261. (Pubitemid 43271657)
8. Croce CM, Calin GA,. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7. (Pubitemid 40977933)
9. Kent OA, Mendell JT,. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188-6196. (Pubitemid 44527849)
10. Couto-Moraes R, Palermo-Neto J, Markus RP,. The immune-pineal axis: stress as a modulator of pineal gland function. Ann N Y Acad Sci 2009; 1153: 193-202.
11. Dollins AB, Zhdanova IV, Wurtman RJ, et al., Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994; 91: 1824-1828. (Pubitemid 24080298)
12. Reiter RJ,. Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. Endocrinology 1973; 92: 423-430.
13. Mukherjee D, Roy SG, Bandyopadhyay A, et al., Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 2010; 48: 251-262.
14. Carrillo-Vico A, Lardone PJ, Naji L, et al., Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005; 39: 400-408.
15. Petrosillo G, Moro N, Paradies V, et al., Increased susceptibility to Ca (2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin. J Pineal Res 2010; 48: 340-346.
16. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
17. Reiter RJ, Tan DX, Manchester LC, et al., Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52: 11-28.
18. Hill SM, Frasch T, Xiang S, et al., Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009; 8: 337-346.
19. Joo SS, Yoo YM,. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 2009; 47: 8-14.
20. Cini G, Neri B, Pacini A, et al., Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. J Pineal Res 2005; 39: 12-20. (Pubitemid 40966457)
21. Blask DE, Brainard GC, Dauchy RT, et al., Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005; 65: 11174-11184. (Pubitemid 41713389)
22. Cos S, Sanchez-Barcelo EJ,. Melatonin and mammary pathological growth. Front Neuroendocrinol 2000; 21: 133-170. (Pubitemid 30228502)
23. Cos S, Blask DE,. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J Pineal Res 1994; 17: 25-32.
24. Ma L, Teruya-Feldstein J, Weinberg RA,. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688. (Pubitemid 47552092)
25. Iorio MV, Ferracin M, Liu CG, et al., MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070. (Pubitemid 41161233)
26. Huang Q, Gumireddy K, Schrier M, et al., The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-210. (Pubitemid 351194050)
27. Tavazoie SF, Alarcon C, Oskarsson T, et al., Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
28. Martinez-Campa C, Gonzalez A, Mediavilla MD, et al., Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 2009; 101: 1613-1619.
29. Girgert R, Hanf V, Emons G, et al., Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009; 47: 23-31.
30. Cucina A, Proietti S, D'anselmi F, et al., Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res 2009; 46: 172-180.
31. Lee SH, Lee SE, Ahn HJ, et al., Identification of atherosclerosis related gene expression profiles by treatment of benzo(a)pyrene in human umbilical vein endothelial cells. Mol Cell Toxicol 2009; 5: 113-119.
32. Cos S, Mediavilla MD, Fernandez R, et al., Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 2002; 32: 90-96. (Pubitemid 34289586)
33. Dennis G Jr, Sherman BT, Hosack DA, et al., DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
34. Verghese ET, Hanby AM, Speirs V, et al., Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol 2008; 215: 214-221. (Pubitemid 351956702)
35. Saunders MA, Lim LP,. (micro)Genomic medicine microRNAs as therapeutics and biomarkers. RNA Biol 2009; 6: 324-328.
36. Dharap A, Bowen K, Place R, et al., Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 2009; 29: 675-687.
37. Kuhn DE, Nuovo GJ, Martin MM, et al., Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun 2008; 370: 473-477.
38. Lu J, Getz G, Miska EA, et al., MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
39. Blask DE, Dauchy RT, Sauer LA,. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27: 179-188. (Pubitemid 41558450)
40. Mediavilla MD, Cos S, Sanchez-Barcelo EJ,. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 1999; 65: 415-420. (Pubitemid 29325284)
41. Leja-Szpak A, Jaworek J, Pierzchalski P, et al., Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 49: 248-255.
42. Um HJ, Kwon TK,. Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells. J Pineal Res 2010; 49: 283-290.
43. Futagami M, Sato S, Sakamoto T, et al., Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells. Gynecol Oncol 2001; 82: 544-549. (Pubitemid 32826457)
44. Martin-Renedo J, Mauriz JL, Jorquera F, et al., Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45: 532-540.
45. Boren T, Xiong Y, Hakam A, et al., MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol 2008; 110: 206-215.
46. Blower PE, Verducci JS, Lin S, et al., MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 2007; 6: 1483-1491. (Pubitemid 46954015)
47. Qiao M, Wang Y, Xu X, et al., Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Mol Cell 2010; 38: 512-523.
48. Gao T, Furnari F, Newton AC,. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005; 18: 13-24. (Pubitemid 40444644)
49. Zhang C, Chakravarty D, Sakabe I, et al., Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther 2006; 13: 947-955.
50. Yasuoka H, Kodama R, Tsujimoto M, et al., Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer 2009; 9: 220.